Getting Vimizim (Elosulfase Alfa) Covered by Humana in Ohio: PA Forms, Appeals Process, and State Resources

Answer Box: Your Path to Vimizim Coverage in Ohio

Vimizim (elosulfase alfa) requires prior authorization from Humana in Ohio. Submit PA requests through Humana's provider portal or fax to Gainwell Pharmacy Services at 833-679-5491. Include confirmed MPS IVA diagnosis, GALNS enzyme deficiency results, prescriber specialty documentation, and baseline functional measures. If denied, you have 65 days to appeal internally, then 180 days for Ohio external review through the Ohio Department of Insurance (1-800-686-1526). Start by verifying your specific Humana plan type and gathering diagnostic documentation.

Table of Contents

Coverage at a Glance

Requirement Details Where to Find Source
PA Required? Yes, for all Humana plans in Ohio Humana PA Lists Humana 2024-2026
HCPCS Code J1322 FDA labeling FDA
Formulary Status Specialty tier, PA required Humana formulary Provider Portal
Age Restrictions Typically ≥5 years Similar Ohio plans CareSource Policy
Prescriber Type Geneticist/metabolic specialist Standard criteria Multiple payer policies
Appeal Deadline 65 days (internal) Humana policy Member Appeals
External Review 180 days from final denial Ohio law ODI External Review

Step 1: Verify Your Plan and Find the Right Forms

First, confirm your specific Humana plan type because submission processes differ:

  • Humana Medicare Advantage: Use standard Humana PA process
  • Humana Healthy Horizons (Ohio Medicaid): Submit through Gainwell Technologies portal
  • Commercial Humana plans: Standard provider portal submission
Tip: Check your member ID card. Ohio Medicaid members will see "Healthy Horizons" branding and should follow the Medicaid-specific process below.

Find your member ID and policy details by logging into MyHumana or calling member services at the number on your card.

Step 2: Prior Authorization Forms and Requirements

Required Documentation for Vimizim PA

Based on Humana's Ohio Medicaid PA requirements and similar payer criteria, submit:

Clinical Documentation:

  • Confirmed MPS IVA diagnosis via GALNS enzyme deficiency testing
  • Genetic testing results showing relevant mutations
  • Urinary keratan sulfate (uKS) levels
  • ICD-10 diagnosis code (E76.219 - Morquio syndrome)
  • Baseline functional assessments (6-minute walk test, pulmonary function)

Prescriber Information:

  • Specialty: Medical genetics, metabolic disorders, or pediatric subspecialty
  • DEA number and NPI
  • Clinical rationale for treatment initiation

Treatment Plan:

  • Weight-based dosing (2 mg/kg IV weekly)
  • Site of care (infusion center or hospital)
  • Monitoring plan for efficacy and safety

Medical Necessity Letter Template

Your prescriber should include these elements in the medical necessity letter:

  1. Patient presentation: Age, weight, specific symptoms, functional limitations
  2. Diagnostic confirmation: Lab results, genetic testing, imaging if relevant
  3. Disease progression: How MPS IVA is impacting the patient's daily life
  4. Treatment rationale: Why Vimizim is appropriate at this time
  5. Expected outcomes: Measurable goals (improved mobility, reduced uKS levels)
  6. Alternative considerations: Why other supportive care is insufficient

Step 3: Submission Portals and Methods

For Ohio Medicaid (Humana Healthy Horizons)

Primary submission method: Gainwell Technologies portal

  • Phone: 833-491-0344 (TTY 833-655-2437)
  • Fax: 833-679-5491
  • Online: Electronic submission through Gainwell provider portal

For Medicare Advantage and Commercial Plans

Humana Provider Portal: provider.humana.com

  • Phone: 1-800-555-2546 (CLIN), Monday-Friday 8 AM-8 PM
  • Fax: Check your specific plan's PA fax number in the provider manual
Note: Create a provider portal account in advance. Electronic submissions typically process faster than fax submissions.

Step 4: Specialty Pharmacy Requirements

Vimizim must be dispensed through a specialty pharmacy due to its complex storage and administration requirements.

Humana's preferred specialty pharmacy: CenterWell Specialty Pharmacy

  • Phone: 1-800-486-2668 (TTY: 711)
  • Hours: Monday-Friday 8 AM-8 PM, Saturday 8 AM-6 PM Eastern
  • Fax for prescriptions: 1-877-405-7940

Transfer process:

  1. Your doctor sends the prescription to CenterWell
  2. CenterWell contacts you to coordinate delivery and infusion scheduling
  3. They handle PA submission if not already completed
  4. Medication ships to your infusion center with cold-chain management

Step 5: Appeals Process - Internal and External

Internal Appeals with Humana

Timeline: File within 65 days of denial notice Decision timeframe: 7 days standard, 24-72 hours expedited

How to file:

  • Online: MyHumana portal
  • Phone: 877-486-2621
  • Mail: Address provided in your denial letter
  • Fax: 877-486-2621

Required for appeal:

  • Copy of denial letter
  • Medical necessity documentation addressing specific denial reason
  • Updated clinical notes showing disease progression
  • Peer-reviewed literature supporting Vimizim use in MPS IVA

Ohio External Review Process

If Humana upholds the denial after internal appeals, Ohio law provides external review through independent medical experts.

Eligibility: Available for medical necessity denials, not contractual exclusions Timeline: Request within 180 days of final Humana denial Cost: No fee to the patient

How to request:

  • Contact: Ohio Department of Insurance at 1-800-686-1526
  • Email: [email protected]
  • Process: ODI assigns an Independent Review Organization (IRO)
  • Decision: Binding on Humana if overturned
Important: For self-funded employer plans, federal ERISA law may apply instead of Ohio's external review process.

Common Denial Reasons and How to Fix Them

Denial Reason How to Address Documentation Needed
"Diagnosis not confirmed" Submit enzyme testing results GALNS deficiency lab report, genetic testing
"Prescriber not qualified" Verify specialist credentials Board certification in genetics/metabolism
"Lack of medical necessity" Document functional decline 6-minute walk test, PFTs, quality of life measures
"Alternative therapy available" Explain why supportive care insufficient Treatment history, progression despite care
"Site of care inappropriate" Justify infusion center use Safety requirements, monitoring needs

The success rate for specialty drug appeals with peer-to-peer consultation is 82-88%, making this a critical strategy.

Support and Contact Numbers

Member Services

  • General Humana: Number on your member ID card
  • CenterWell Specialty: 1-800-486-2668
  • 24/7 urgent specialty questions: 1-855-746-0637

Provider Services

  • PA requests: 1-800-555-2546
  • Peer-to-peer consultations: Available through provider portal
  • Clinical pharmacy review: For complex cases requiring medical director input

Case Management

For rare disease medications like Vimizim, request assignment to a case manager who can coordinate between your medical team, specialty pharmacy, and insurance approvals.

Ohio-Specific Consumer Protections

Ohio provides strong consumer protections for insurance appeals:

External Review Rights:

  • Independent medical review by qualified physicians
  • 180-day filing deadline from final insurer denial
  • Expedited review available if delay would jeopardize health
  • Decision is binding on the insurance company

Consumer Assistance:

  • Ohio Department of Insurance: 1-800-686-1526
  • OSHIIP (for Medicare issues): 1-800-686-1578
  • UHCAN Ohio: Nonprofit advocacy for health coverage issues

Key Ohio Advantage: Even if Humana claims your case isn't eligible for external review, the Ohio Department of Insurance can independently determine eligibility and order a review.

FAQ

How long does Humana prior authorization take for Vimizim in Ohio? Standard PA decisions are made within 72 hours for specialty medications. Expedited requests (when delay could harm the patient) are decided within 24 hours.

What if Vimizim is not on Humana's formulary? You can request a formulary exception based on medical necessity. This requires demonstrating that formulary alternatives are inappropriate or have been tried and failed.

Can I get an expedited appeal if treatment is urgent? Yes, if delaying treatment could seriously jeopardize your health. Your doctor must provide documentation supporting the urgency of treatment.

Does step therapy apply to Vimizim? Step therapy typically doesn't apply since there are no alternative enzyme replacement therapies for MPS IVA. However, Humana may require documentation of supportive care attempts.

What happens if I move to another state? Coverage continues under your Humana plan, but appeal rights would follow the laws of your new state. Specialty pharmacy coordination may need adjustment.

How much does Vimizim cost without insurance? Annual costs range from approximately $700,000 to $2.1 million based on patient weight, making insurance coverage essential for access.


At Counterforce Health, we help patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by creating targeted, evidence-backed responses. Our platform analyzes denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific requirements, pulling the right citations and clinical facts to support medical necessity arguments.

When navigating Vimizim coverage with Humana in Ohio, having the right documentation and understanding the specific requirements can make the difference between approval and denial. While the PA process may seem complex, Humana's relatively low denial rate of approximately 3.5% for Medicare Advantage plans suggests that well-documented requests often succeed. The key is submitting complete clinical evidence that directly addresses their criteria and being prepared to appeal if necessary.

For the most current forms and submission processes, always verify information through Humana's provider portal or by calling their PA department directly. Requirements and processes can change, and having the most up-to-date information ensures the smoothest path to approval.

Disclaimer: This information is for educational purposes only and is not medical or legal advice. Always consult with your healthcare provider about treatment decisions and verify current insurance requirements directly with Humana and Ohio regulators.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.